http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1359979-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
| filingDate | 2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a9fff57e7e747203fc69a84db8ad641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_504e66937fa6e9de626743b84ca71d9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc8a936864b783c18d43dddb11fc2476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be31b099aaa2b2ad1c5ffc62c314f83 |
| publicationDate | 2003-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1359979-A2 |
| titleOfInvention | Anti cancer combination of substituted pyrroles and paclitaxel |
| abstract | Disclosed is a process of treating a patient suffering from cancer. The process compriese administering to a patient over a period of up to about 15 days a first component and a second component. The first component consists of a pharmaceutical composition containin as an active ingreadient a compound of formula (I) or a pharmaceutically acceptable salt or ester of said compound. the second ocmponenet consists of a n injection solution containing as an active ingredient paclitaxel. The amount of each componet in the combination is such that the combination is therapeutically effective. The components are administered concomitantly or sequentially ina three week to four week treatment cycle for as long as the tumor remains under control and the patient tolerates the regimen. |
| priorityDate | 2001-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.